• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Colgate Announces 1st Quarter 2025 Results

    4/25/25 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $CL alert in real time by email

    Colgate-Palmolive Company (NYSE:CL):

    • Net sales decreased 3.1%; Organic sales* increased 1.4%, including a 0.4% negative impact from lower private label pet volume; foreign exchange was a 4.4% headwind to net sales
    • GAAP EPS increased 2% to $0.85; Base Business EPS* increased 6% to $0.91
    • GAAP Gross profit margin and Base Business Gross profit margin* increased 80 basis points to 60.8%
    • Net cash provided by operations was $600 million for the first three months of 2025
    • Colgate's leadership in toothpaste continued with its global market share at 40.9% year to date
    • Colgate's leadership in manual toothbrushes continued with its global market share at 31.9% year to date
    • The Company updated its financial guidance for full year 2025

    First Quarter Total Company Results (GAAP)

    ($ in millions except per share amounts)

    2025

    2024

    Change

    Net Sales

    $4,911

    $5,065

    -3.1%

    EPS (diluted)

    $0.85

    $0.83

    +2%

     

     

     

     

     

     

     

     

    First Quarter Total Company Results (Base Business - Non-GAAP)*

     

    2025

    2024

    Change

    Organic Sales Growth

    +1.4%

    Base Business EPS (diluted)

    $0.91

    $0.86

    +6%

    *Indicates a non-GAAP financial measure. Please refer to "Non-GAAP Financial Measures" later in this release for definitions of non-GAAP financial measures and to "Table 5 - Geographic Sales Analysis Percentage Changes" and "Table 6 - Non-GAAP Reconciliations" included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

    Colgate-Palmolive Company (NYSE:CL) today reported results for first quarter 2025. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business first quarter results, "Colgate-Palmolive people delivered another quarter of organic sales and earnings per share growth in the face of very difficult market conditions worldwide. The positive organic sales growth, in a period of slowing category growth in many markets, is a testament to the strength of our brands and our commitment to executing against our strategy.

    "Our focus on building flexibility into our P&L enabled us to deliver year-over-year growth in operating profit, net income and earnings per share despite the volatile operating environment. The leverage in our P&L also funded a 30 basis point increase in advertising to 13.6% to sales, as we continue to invest to drive brand health and increase household penetration.

    "As we look ahead, uncertainty and volatility in global markets, including the impact of tariffs, remain challenging. We are confident in our strategy and will continue to execute with focus and agility to mitigate these factors and achieve our revised 2025 financial targets."

    Full Year 2025 Guidance

    Based on current spot rates and including the estimated impact of tariffs announced and in effect as of April 24, 2025:

    • The Company now expects net sales to be up low single digits, including a low-single-digit negative impact from foreign exchange.
    • The Company now expects organic sales growth to be 2% to 4%.
    • On a GAAP basis, the Company now expects both gross profit margin and advertising investment to be roughly flat as a percentage of net sales, and earnings per share to be up low single digits.
    • On a non-GAAP (Base Business) basis, the Company now expects both gross profit margin and advertising to be roughly flat as a percentage of net sales, and earnings per share to be up low single digits.

    Divisional Performance

    See attached "Table 5 - Geographic Sales Analysis Percentage Changes" and "Table 4 - Segment Information" for additional information on net sales and operating profit by division.

    First Quarter Sales Growth By Division

    (% change 1Q 2025 vs. 1Q 2024 except % of Total Company Sales)

     

     

     

    % of Total

    Company

    Sales

    Net

    Sales

    Organic

    Sales*

     

    Volume

    Pricing

    FX

    North America(1)

    20%

    -3.6%

    -3.0%

    -2.3%

    -0.7%

    -0.6%

    Latin America

    23%

    -8.7%

    +4.0%

    +2.7%

    +1.2%

    -12.7%

    Europe(1)

    14%

    +2.5%

    +5.4%

    +3.0%

    +2.4%

    -2.9%

    Asia Pacific

    14%

    -5.0%

    -3.1%

    -3.4%

    +0.4%

    -1.9%

    Africa/Eurasia

    6%

    -1.5%

    +1.8%

    -2.3%

    +4.1%

    -3.4%

    Hill's

    23%

    +1.5%

    +2.9%

    -0.3%

    +3.2%

    -1.4%

     

     

     

     

     

     

     

    Total Company

    100%

    -3.1%

    +1.4%

    -0.1%

    +1.5%

    -4.4%

    Note: Table may not sum due to rounding.  

     

    (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024. The results of the skin health business previously reported within the Europe reportable operating segment are reported with the other skin health businesses in the North America reportable operating segment. Recast historical geographic segment information can be found on the Company's website.

     

    *Indicates a non-GAAP financial measure. Please refer to "Non-GAAP Financial Measures" later in this release for definitions of non-GAAP financial measures and to "Table 5 - Geographic Sales Analysis Percentage Changes" included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures. 

    First Quarter Operating Profit By Division

    ($ in millions)

     

     

    1Q 2025

    % Change vs

    1Q 2024

    % to Net

    Sales

    Change in basis

    points vs 1Q 2024

    % to Net Sales

    North America(1)

    $196

    -8%

    19.6%

    -100

    Latin America

    $348

    -14%

    30.4%

    -190

    Europe(1)

    $172

    12%

    24.9%

    +220

    Asia Pacific

    $198

    -4%

    28.7%

    +20

    Africa/Eurasia

    $57

    -14%

    21.0%

    -290

    Hill's

    $258

    30%

    23.1%

    +510

     

     

     

     

     

    Total Company, As Reported

    $1,076

    3%

    21.9%

    +120

    Total Company, Base Business*

    $1,091

    1%

    22.2%

    +80

    (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.  

     

    *Indicates a non-GAAP financial measure. Please refer to "Non-GAAP Financial Measures" later in this release for definitions of non-GAAP financial measures and to "Table 6 - Non-GAAP Reconciliations" included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

    Prepared Materials and Webcast Information

    At approximately 7:00 a.m. ET today, Colgate will post its prepared materials regarding first quarter results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.

    At 8:30 a.m. ET today, Colgate will host a conference call regarding first quarter results. To access this call as a webcast, please go to Colgate's website at www.colgatepalmolive.com.

    About Colgate-Palmolive

    Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. The Company is recognized for its leadership and innovation in promoting sustainability and community wellbeing, including its achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children's oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.8 billion children and their families since 1991. For more information about Colgate's global business and how the Company is building a future to smile about, visit www.colgatepalmolive.com. CL-E

    Market Share Information

    Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

    Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

    Cautionary Statement on Forward-Looking Statements

    This press release and the related webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management's current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, the impact of foreign exchange, the impact of tariffs, the impact of geopolitical conflicts and tensions, such as the war in Ukraine, the conflict in the Middle East, tensions between China and Taiwan and global trade relations, cost reduction plans, tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company's views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company's business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company's filings with the SEC (including, but not limited to, the information set forth under the captions "Risk Factors" and "Cautionary Statement on Forward-Looking Statements" in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company's Investor Relations Department or on the Company's website at www.colgatepalmolive.com.

    Non-GAAP Financial Measures

    The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:

    • Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges related to the ERISA litigation matter and the 2022 Global Productivity Initiative.
    • Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
    • Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

    This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company's underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See "Geographic Sales Analysis Percentage Changes" for the three months ended March 31, 2025 versus 2024 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

    Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company's normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company's business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company's underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See "Non-GAAP Reconciliations" for the three months ended March 31, 2025 and 2024 included with this release for a reconciliation of these financial measures to the related GAAP measures.

    The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

    As management uses free cash flow before dividends to evaluate the Company's ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See "Condensed Consolidated Statements of Cash Flows" for the three months ended March 31, 2025 and 2024 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

    (See attached tables for first quarter results.)

     

     

     

     

    Table 1

    Colgate-Palmolive Company

     

    Condensed Consolidated Statements of Income

     

    For the Three Months Ended March 31, 2025 and 2024

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

     

    2025

     

    2024

     

     

     

     

     

    Net sales

     

    $

    4,911

     

     

    $

    5,065

     

     

     

     

     

     

    Cost of sales

     

     

    1,924

     

     

     

    2,026

     

     

     

     

     

     

    Gross profit

     

     

    2,987

     

     

     

    3,039

     

     

     

     

     

     

    Gross profit margin

     

     

    60.8

    %

     

     

    60.0

    %

     

     

     

     

     

    Selling, general and administrative expenses

     

     

    1,898

     

     

     

    1,916

     

     

     

     

     

     

    Other (income) expense, net

     

     

    13

     

     

     

    76

     

     

     

     

     

     

    Operating profit

     

     

    1,076

     

     

     

    1,047

     

     

     

     

     

     

    Operating profit margin

     

     

    21.9

    %

     

     

    20.7

    %

     

     

     

     

     

    Non-service related postretirement costs

     

     

    72

     

     

     

    22

     

     

     

     

     

     

    Interest expense

     

     

    66

     

     

     

    73

     

     

     

     

     

     

    Interest income

     

     

    15

     

     

     

    15

     

     

     

     

     

     

    Income before income taxes

     

     

    953

     

     

     

    967

     

     

     

     

     

     

    Provision for income taxes

     

     

    227

     

     

     

    238

     

     

     

     

     

     

    Effective tax rate

     

     

    23.7

    %

     

     

    24.6

    %

     

     

     

     

     

    Net income including noncontrolling interests

     

     

    726

     

     

     

    729

     

     

     

     

     

     

    Less: Net income attributable to noncontrolling interests

     

     

    36

     

     

     

    46

     

     

     

     

     

     

    Net income attributable to Colgate-Palmolive Company

     

    $

    690

     

     

    $

    683

     

     

     

     

     

     

    Earnings per common share

     

     

     

     

    Basic

     

    $

    0.85

     

     

    $

    0.83

     

    Diluted

     

    $

    0.85

     

     

    $

    0.83

     

     

     

     

     

     

    Supplemental Income Statement Information

     

     

     

     

    Average common shares outstanding

     

     

     

     

    Basic

     

     

    812.0

     

     

     

    822.8

     

    Diluted

     

     

    815.0

     

     

     

    825.9

     

     

     

     

     

     

    Advertising

     

    $

    668

     

     

    $

    672

     

     

     

     

     

     

     

    Table 2

    Colgate-Palmolive Company

     

    Condensed Consolidated Balance Sheets

     

    As of March 31, 2025, December 31, 2024 and March 31, 2024

     

    (Dollars in Millions) (Unaudited)

     

     

     

     

     

     

     

     

     

    March 31,

     

    December 31,

     

    March 31,

     

     

    2025

     

    2024

     

    2024

    Cash and cash equivalents

     

    $

    1,112

     

     

    $

    1,096

     

     

    $

    1,079

     

    Receivables, net

     

     

    1,725

     

     

     

    1,521

     

     

     

    1,813

     

    Inventories

     

     

    2,125

     

     

     

    1,987

     

     

     

    1,914

     

    Other current assets

     

     

    852

     

     

     

    713

     

     

     

    834

     

    Property, plant and equipment, net

     

     

    4,416

     

     

     

    4,422

     

     

     

    4,497

     

    Goodwill

     

     

    3,334

     

     

     

    3,272

     

     

     

    3,341

     

    Other intangible assets, net

     

     

    1,782

     

     

     

    1,756

     

     

     

    1,837

     

    Other assets

     

     

    1,301

     

     

     

    1,279

     

     

     

    1,256

     

    Total assets

     

    $

    16,647

     

     

    $

    16,046

     

     

    $

    16,571

     

     

     

     

     

     

     

     

    Total debt

     

    $

    8,269

     

     

    $

    7,949

     

     

    $

    8,689

     

    Other current liabilities

     

     

    5,163

     

     

     

    5,099

     

     

     

    4,776

     

    Other non-current liabilities

     

     

    2,482

     

     

     

    2,454

     

     

     

    2,489

     

    Total liabilities

     

     

    15,914

     

     

     

    15,502

     

     

     

    15,954

     

    Total Colgate-Palmolive Company shareholders' equity

     

     

    363

     

     

     

    212

     

     

     

    230

     

    Noncontrolling interests

     

     

    370

     

     

     

    332

     

     

     

    387

     

    Total liabilities and equity

     

    $

    16,647

     

     

    $

    16,046

     

     

    $

    16,571

     

     

     

     

     

     

     

     

    Supplemental Balance Sheet Information

     

     

     

     

     

     

    Debt less cash, cash equivalents and marketable securities(1)

     

    $

    6,958

     

     

    $

    6,693

     

     

    $

    7,379

     

    Working capital % of sales

     

     

    (3.3

    )%

     

     

    (5.2

    )%

     

     

    (2.2

    )%

    Note:

    (1) Marketable securities of $199, $160 and $231 as of March 31, 2025, December 31, 2024 and March 31, 2024, respectively, are included in Other current assets.

     

     

     

     

    Table 3

    Colgate-Palmolive Company

     

    Condensed Consolidated Statements of Cash Flows

     

    For the Three Months Ended March 31, 2025 and 2024

     

    (Dollars in Millions) (Unaudited)

     

     

     

     

     

     

     

    2025

     

    2024

    Operating Activities

     

     

     

     

    Net income including noncontrolling interests

     

    $

    726

     

     

    $

    729

     

    Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations:

     

     

    Depreciation and amortization

     

     

    148

     

     

     

    150

     

    ERISA litigation matter

     

     

    65

     

     

     

    —

     

    Restructuring and termination benefits, net of cash

     

     

    (7

    )

     

     

    30

     

    Stock-based compensation expense

     

     

    23

     

     

     

    19

     

    Deferred income taxes

     

     

    (24

    )

     

     

    12

     

    Cash effects of changes in:

     

     

     

     

    Receivables

     

     

    (174

    )

     

     

    (252

    )

    Inventories

     

     

    (86

    )

     

     

    11

     

    Accounts payable and other accruals

     

     

    (57

    )

     

     

    8

     

    Other non-current assets and liabilities

     

     

    (14

    )

     

     

    (26

    )

    Net cash provided by (used in) operations

     

     

    600

     

     

     

    681

     

     

     

     

     

     

    Investing Activities

     

     

     

     

    Capital expenditures

     

     

    (124

    )

     

     

    (126

    )

    Purchases of marketable securities and investments

     

     

    (134

    )

     

     

    (139

    )

    Proceeds from sale of marketable securities and investments

     

     

    97

     

     

     

    78

     

    Other investing activities

     

     

    2

     

     

     

    (6

    )

    Net cash provided by (used in) investing activities

     

     

    (159

    )

     

     

    (193

    )

     

     

     

     

     

    Financing Activities

     

     

     

     

    Short-term borrowing (repayment) less than 90 days, net

     

     

    164

     

     

     

    728

     

    Principal payments on debt

     

     

    (4

    )

     

     

    (500

    )

    Proceeds from issuance of debt

     

     

    —

     

     

     

    1

     

    Dividends paid

     

     

    (406

    )

     

     

    (394

    )

    Purchases of treasury shares

     

     

    (284

    )

     

     

    (509

    )

    Proceeds from exercise of stock options

     

     

    40

     

     

     

    336

     

    Other financing activities

     

     

    32

     

     

     

    (23

    )

    Net cash provided by (used in) financing activities

     

     

    (458

    )

     

     

    (361

    )

     

     

     

     

     

    Effect of exchange rate changes on Cash and cash equivalents

     

     

    33

     

     

     

    (14

    )

    Net increase (decrease) in Cash and cash equivalents

     

     

    16

     

     

     

    113

     

    Cash and cash equivalents at beginning of the period

     

     

    1,096

     

     

     

    966

     

    Cash and cash equivalents at end of the period

     

    $

    1,112

     

     

    $

    1,079

     

    Supplemental Cash Flow Information

     

     

     

     

    Free cash flow before dividends (Net cash provided by operations less Capital expenditures)

     

     

     

     

    Net cash provided by operations

     

    $

    600

     

     

    $

    681

     

    Less: Capital expenditures

     

     

    (124

    )

     

     

    (126

    )

    Free cash flow before dividends

     

    $

    476

     

     

    $

    555

     

     

     

     

     

     

     

     

     

     

     

    Income taxes paid

     

    $

    139

     

     

    $

    150

     

    Interest paid

     

    $

    109

     

     

    $

    123

     

     

     

     

     

    Table 4

    Colgate-Palmolive Company

     

    Segment Information

     

    For the Three Months Ended March 31, 2025 and 2024

     

    (Dollars in Millions) (Unaudited)

     

     

     

     

     

    Three Months Ended March 31,

     

     

    2025

     

    2024

    Net Sales

     

     

     

     

    Oral, Personal and Home Care

     

     

     

     

     

     

     

     

     

    North America(1)

     

    $

    998

     

     

    $

    1,035

     

    Latin America

     

     

    1,143

     

     

     

    1,253

     

    Europe(1)

     

     

    690

     

     

     

    673

     

    Asia Pacific

     

     

    690

     

     

     

    727

     

    Africa/Eurasia

     

     

    271

     

     

     

    276

     

     

     

     

     

     

    Total Oral, Personal and Home Care

     

     

    3,792

     

     

     

    3,963

     

     

     

     

     

     

    Pet Nutrition

     

     

    1,118

     

     

     

    1,102

     

     

     

     

     

     

    Total Net Sales

     

    $

    4,911

     

     

    $

    5,065

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended March 31,

     

     

    2025

     

    2024

    Operating Profit

     

     

     

     

    Oral, Personal and Home Care

     

     

     

     

     

     

     

     

     

    North America(1)

     

    $

    196

     

     

    $

    214

     

    Latin America

     

     

    348

     

     

     

    405

     

    Europe(1)

     

     

    172

     

     

     

    153

     

    Asia Pacific

     

     

    198

     

     

     

    207

     

    Africa/Eurasia

     

     

    57

     

     

     

    66

     

     

     

     

     

     

    Total Oral, Personal and Home Care

     

     

    971

     

     

     

    1,044

     

     

     

     

     

     

    Pet Nutrition

     

     

    258

     

     

     

    199

     

    Corporate(2)

     

     

    (153

    )

     

     

    (196

    )

     

     

     

     

     

    Total Operating Profit

     

    $

    1,076

     

     

    $

    1,047

     

    Tables may not sum due to rounding.

     

    Notes:

    (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

     

    (2) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. 

     

    Corporate Operating profit (loss) for the three months ended March 31, 2025 included charges related to the ERISA litigation matter of $15.

     

    Corporate Operating profit (loss) for the three months ended March 31, 2024 included charges resulting from the 2022 Global Productivity Initiative of $36.

    Table 5

    Colgate-Palmolive Company

     

    Geographic Sales Analysis Percentage Changes

     

    For the Three Months Ended March 31, 2025 vs. 2024

     

    (Unaudited)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    COMPONENTS OF SALES CHANGE

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Pricing

     

     

     

     

     

     

     

     

     

     

    Coupons

     

     

     

     

    Sales

     

     

     

     

     

    Consumer &

     

     

     

     

    Change

     

    Organic

     

     

     

    Trade

     

    Foreign

    Region

     

    As Reported

     

    Sales Change

     

    Volume

     

    Incentives

     

    Exchange

     

     

     

     

     

     

     

     

     

     

     

    Total Company

     

    (3.1

    )%

     

    1.4

    %

     

    (0.1

    )%

     

    1.5

    %

     

    (4.4

    )%

     

     

     

     

     

     

     

     

     

     

     

    North America(1)

     

    (3.6

    )%

     

    (3.0

    )%

     

    (2.3

    )%

     

    (0.7

    )%

     

    (0.6

    )%

     

     

     

     

     

     

     

     

     

     

     

    Latin America

     

    (8.7

    )%

     

    4.0

    %

     

    2.7

    %

     

    1.2

    %

     

    (12.7

    )%

     

     

     

     

     

     

     

     

     

     

     

    Europe(1)

     

    2.5

    %

     

    5.4

    %

     

    3.0

    %

     

    2.4

    %

     

    (2.9

    )%

     

     

     

     

     

     

     

     

     

     

     

    Asia Pacific

     

    (5.0

    )%

     

    (3.1

    )%

     

    (3.4

    )%

     

    0.4

    %

     

    (1.9

    )%

     

     

     

     

     

     

     

     

     

     

     

    Africa/Eurasia

     

    (1.5

    )%

     

    1.8

    %

     

    (2.3

    )%

     

    4.1

    %

     

    (3.4

    )%

     

     

     

     

     

     

     

     

     

     

     

    Total CP Products

     

    (4.3

    )%

     

    1.0

    %

     

    —

    %

     

    1.0

    %

     

    (5.3

    )%

     

     

     

     

     

     

     

     

     

     

     

    Hill's

     

    1.5

    %

     

    2.9

    %

     

    (0.3

    )%

     

    3.2

    %

     

    (1.4

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Emerging Markets(2)

     

    (6.2

    )%

     

    1.7

    %

     

    0.2

    %

     

    1.4

    %

     

    (7.9

    )%

     

     

     

     

     

     

     

     

     

     

     

    Developed Markets

     

    (0.4

    )%

     

    1.1

    %

     

    (0.4

    )%

     

    1.5

    %

     

    (1.5

    )%

    Table may not sum due to rounding.

     

    Notes:

    (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

     

    (2) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

    Table 6

    Colgate-Palmolive Company

     

    Non-GAAP Reconciliations

     

    For the Three Months Ended March 31, 2025 and 2024

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Selling, General and Administrative Expenses

     

    2025

     

    2024

     

     

    Selling, general and administrative expenses, GAAP

     

    $

    1,898

     

     

    $

    1,916

     

     

     

    ERISA litigation matter

     

     

    (15

    )

     

     

    —

     

     

     

    2022 Global Productivity Initiative

     

     

    —

     

     

     

    (1

    )

     

     

    Selling, general and administrative expenses, non-GAAP

     

    $

    1,883

     

     

    $

    1,915

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basis Point

    Selling, General and Administrative Expenses as a Percentage of Net Sales

     

    2025

     

    2024

     

    Change

    Selling, general and administrative expenses as a percentage of Net sales, GAAP

     

     

    38.6

    %

     

     

    37.8

    %

     

    80

     

    ERISA litigation matter

     

     

    (0.3

    )%

     

     

    —

    %

     

     

    Selling, general and administrative expenses as a percentage of Net sales, non-GAAP

     

     

    38.3

    %

     

     

    37.8

    %

     

    50

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Other (Income) Expense, Net

     

    2025

     

    2024

     

     

    Other (income) expense, net, GAAP

     

    $

    13

     

     

    $

    76

     

     

     

    2022 Global Productivity Initiative

     

     

    —

     

     

     

    (35

    )

     

     

    Other (income) expense, net, non-GAAP

     

    $

    13

     

     

    $

    41

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Operating Profit

     

    2025

     

    2024

     

    % Change

    Operating profit, GAAP

     

    $

    1,076

     

     

    $

    1,047

     

     

    3

    %

    ERISA litigation matter

     

     

    15

     

     

     

    —

     

     

     

    2022 Global Productivity Initiative

     

     

    —

     

     

     

    36

     

     

     

    Operating profit, non-GAAP

     

    $

    1,091

     

     

    $

    1,083

     

     

    1

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basis Point

    Operating Profit Margin

     

    2025

     

    2024

     

    Change

    Operating profit margin, GAAP

     

     

    21.9

    %

     

     

    20.7

    %

     

    120

     

    ERISA litigation matter

     

     

    0.3

    %

     

     

    —

    %

     

     

    2022 Global Productivity Initiative

     

     

    —

    %

     

     

    0.7

    %

     

     

    Operating profit margin, non-GAAP

     

     

    22.2

    %

     

     

    21.4

    %

     

    80

     

     

     

     

     

     

     

     

     

    Non-Service Related Postretirement Costs

     

    2025

     

    2024

     

     

    Non-service related postretirement costs, GAAP

     

    $

    72

     

     

    $

    22

     

     

     

    ERISA litigation matter

     

     

    (50

    )

     

     

    —

     

     

     

    Non-service related postretirement costs, non-GAAP

     

    $

    22

     

     

    $

    22

     

     

     

    Table 6

     

    Continued

    Colgate-Palmolive Company

     

    Non-GAAP Reconciliations

     

    For the Three Months Ended March 31, 2025 and 2024

     

    (Dollars in Millions Except Per Share Amounts) (Unaudited)

     

     

    2025

     

    Income

    Before

    Income

    Taxes

     

    Provision

    For

    Income

    Taxes(1)

     

    Net Income

    Including

    Noncontrolling

    Interests

     

    Less: Income

    Attributable to

    Noncontrolling

    Interests

     

    Net Income

    Attributable

    To

    Colgate-

    Palmolive

    Company

     

    Effective

    Income

    Tax Rate(2)

     

    Diluted

    Earnings

    Per Share

    As Reported GAAP

    $

    953

     

    $

    227

     

    $

    726

     

    $

    36

     

    $

    690

     

    23.7

    %

     

    $

    0.85

    ERISA litigation matter

     

    65

     

     

    12

     

     

    53

     

     

    —

     

     

    53

     

    (0.3

    )%

     

    0.06

    Non-GAAP

    $

    1,018

     

    $

    239

     

    $

    779

     

    $

    36

     

    $

    743

     

    23.4

    %

     

    $

    0.91

     

     

     

    2024

     

    Income

    Before

    Income

    Taxes

     

    Provision

    For

    Income

    Taxes(1)

     

    Net Income

    Including

    Noncontrolling

    Interests

     

    Less: Income

    Attributable to

    Noncontrolling

    Interests

     

    Net Income

    Attributable

    To

    Colgate-

    Palmolive

    Company

     

    Effective

    Income

    Tax Rate(2)

     

    Diluted

    Earnings

    Per Share

    As Reported GAAP

    $

    967

     

    $

    238

     

    $

    729

     

    $

    46

     

    $

    683

     

    24.6

    %

     

    $

    0.83

    2022 Global Productivity Initiative

     

    36

     

     

    6

     

     

    30

     

     

    —

     

     

    30

     

    (0.3

    )%

     

     

    0.03

    Non-GAAP

    $

    1,003

     

    $

    244

     

    $

    759

     

    $

    46

     

    $

    713

     

    24.3

    %

     

    $

    0.86

    The impact of non-GAAP adjustments may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding.

     

    Notes:

    (1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

     

    (2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250425019314/en/

    Investor Relations: [email protected]

    Communications: [email protected]

    Get the next $CL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CL

    DatePrice TargetRatingAnalyst
    10/28/2024$105.00 → $101.00Buy → Hold
    Stifel
    9/24/2024$121.00Overweight
    Piper Sandler
    9/16/2024$100.00Equal Weight → Underweight
    Wells Fargo
    9/9/2024$107.00 → $109.00Buy → Hold
    Deutsche Bank
    7/26/2024Buy → Hold
    HSBC Securities
    7/24/2024$103.00 → $95.00Buy → Hold
    Jefferies
    7/23/2024$110.00Buy
    TD Cowen
    6/24/2024$109.00Outperform
    Exane BNP Paribas
    More analyst ratings

    $CL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Colgate-Palmolive Webcasts Fireside Chat at the Goldman Sachs Global Staples Forum

      Colgate-Palmolive (NYSE:CL) President, Hill's Pet Nutrition, John Hazlin, and Chief Investor Relations Officer and EVP, M&A, John Faucher, will participate in a fireside chat at the Goldman Sachs Global Staples Forum on Tuesday, May 13, 2025 at 8:15 am ET. Investors may access a live webcast of this fireside chat on Colgate's website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center page of Colgate's website. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused o

      4/29/25 10:15:00 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate-Palmolive Webcasts 2025 Annual Meeting of Stockholders May 9, 2025 – 10:00 a.m. ET

      Colgate-Palmolive Company (NYSE:CL) will provide a live video webcast of its 2025 Annual Meeting of Stockholders on Friday, May 9, 2025 at 10:00 a.m. ET. Investors may access the live video webcast at www.virtualshareholdermeeting.com/CL2025. Access will be available beginning at 9:30 a.m. ET. For those unable to participate during the live webcast, a recorded version of the webcast will be made available on the Company's website approximately 24 hours after the meeting concludes. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nu

      4/28/25 9:30:00 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate Announces 1st Quarter 2025 Results

      Colgate-Palmolive Company (NYSE:CL): Net sales decreased 3.1%; Organic sales* increased 1.4%, including a 0.4% negative impact from lower private label pet volume; foreign exchange was a 4.4% headwind to net sales GAAP EPS increased 2% to $0.85; Base Business EPS* increased 6% to $0.91 GAAP Gross profit margin and Base Business Gross profit margin* increased 80 basis points to 60.8% Net cash provided by operations was $600 million for the first three months of 2025 Colgate's leadership in toothpaste continued with its global market share at 40.9% year to date Colgate's leadership in manual toothbrushes continued with its global market share at 31.9% year to date The Company up

      4/25/25 6:55:00 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Colgate-Palmolive downgraded by Stifel with a new price target

      Stifel downgraded Colgate-Palmolive from Buy to Hold and set a new price target of $101.00 from $105.00 previously

      10/28/24 7:38:39 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Piper Sandler initiated coverage on Colgate-Palmolive with a new price target

      Piper Sandler initiated coverage of Colgate-Palmolive with a rating of Overweight and set a new price target of $121.00

      9/24/24 7:35:59 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate-Palmolive downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded Colgate-Palmolive from Equal Weight to Underweight and set a new price target of $100.00

      9/16/24 7:25:35 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    Leadership Updates

    Live Leadership Updates

    See more
    • Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children

      The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi

      2/10/25 6:30:00 AM ET
      $CL
      $HSIC
      Package Goods/Cosmetics
      Consumer Discretionary
      Medical Specialities
      Health Care
    • ZO® Skin Health Appoints Industry Veteran Justin Skala as CEO to Continue Strong Growth

      IRVINE, Calif., March 12, 2024 /PRNewswire/ -- ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE:CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.

      3/12/24 1:08:00 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate-Palmolive Company Appoints Lorrie Norrington as Lead Independent Director of the Board

      Colgate-Palmolive Company (NYSE:CL) today announced that its Board of Directors has appointed Lorrie Norrington as Lead Independent Director, effective March 1, 2023. Ms. Norrington will succeed Stephen I. Sadove, the Company's current Lead Independent Director. Mr. Sadove will remain on the Audit and Personnel and Organization Committees of the Colgate Board of Directors. Ms. Norrington joined the Company's Board in September 2015 and currently serves as Chair of the Nominating, Governance and Corporate Responsibility Committee. She brings extensive global corporate leadership, digital, e-commerce and ESG experience to this role, including her experience in several senior management roles

      1/3/23 4:30:00 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Norrington Lorrie M was granted 2,019 shares, increasing direct ownership by 6% to 38,079 units (SEC Form 4)

      4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

      5/14/25 4:21:59 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Nelson Kimberly A was granted 2,019 shares, increasing direct ownership by 28% to 9,360 units (SEC Form 4)

      4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

      5/14/25 4:22:02 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Newman Brian was granted 2,019 shares, increasing direct ownership by 78% to 4,621 units (SEC Form 4)

      4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

      5/14/25 4:21:55 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    Financials

    Live finance-specific insights

    See more
    • Colgate Announces 1st Quarter 2025 Results

      Colgate-Palmolive Company (NYSE:CL): Net sales decreased 3.1%; Organic sales* increased 1.4%, including a 0.4% negative impact from lower private label pet volume; foreign exchange was a 4.4% headwind to net sales GAAP EPS increased 2% to $0.85; Base Business EPS* increased 6% to $0.91 GAAP Gross profit margin and Base Business Gross profit margin* increased 80 basis points to 60.8% Net cash provided by operations was $600 million for the first three months of 2025 Colgate's leadership in toothpaste continued with its global market share at 40.9% year to date Colgate's leadership in manual toothbrushes continued with its global market share at 31.9% year to date The Company up

      4/25/25 6:55:00 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate-Palmolive Webcasts 2025 First Quarter Earnings Conference Call April 25, 2025 – 8:30 a.m. ET

      Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 first quarter earnings conference call on Friday, April 25, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-presentations. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website. * * * Colg

      4/11/25 9:30:00 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate Announces Dividend Increase and New $5 Billion Share Repurchase Program

      The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today increased the quarterly common stock cash dividend to $.52 up from $.50 per share. The increase will be effective in the second quarter, 2025. The Board declared that the second quarter dividend is to be paid on May 15, 2025 to shareholders of record as of April 17, 2025. On an annual basis, the new dividend rate is $2.08 vs. $2.00 per share previously. The Company has paid uninterrupted dividends on its common stock since 1895. Share Repurchase Program The Board of Directors today also authorized the repurchase of shares of the Company's common stock having an aggregate purchase price of up to $5 billion under a new shar

      3/20/25 4:35:00 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    SEC Filings

    See more
    • Colgate-Palmolive Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

      5/14/25 4:41:05 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • Colgate-Palmolive Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

      5/2/25 4:05:29 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form FWP filed by Colgate-Palmolive Company

      FWP - COLGATE PALMOLIVE CO (0000021665) (Subject)

      4/28/25 5:23:30 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary

    $CL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

      SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

      2/13/24 5:02:36 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

      SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

      2/9/23 11:15:26 AM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

      SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

      2/9/22 3:43:30 PM ET
      $CL
      Package Goods/Cosmetics
      Consumer Discretionary